Evron S, Samueloff A, Sadovsky E, Berger M, Magora F
Eur J Anaesthesiol. 1984 Mar;1(1):45-54.
One hundred and fifty patients, post-Caesarean section, were investigated to evaluate the effect of epidural morphine analgesia and that of phenoxybenzamine on the frequency and extent of urinary complications. Forty patients (group A) underwent Caesarian section under general anaesthesia, while 110 patients received epidural anaesthesia. Of the latter patients, 40 received postoperative mild analgesics (group B) whilst in another 40, postoperative continuous epidural morphine was administered (group C). Thirty patients who received postoperative epidural morphine, also received oral phenoxybenzamine 10 mg, 24 and 1 hr prior to, and 8 and 16 hr following surgery (group D). The volume of urine of the first two postoperative voidings, the time delay to first micturition, difficulty in micturition and urinary retention necessitating bladder catheterization were studied. The mean volumes of the first two postoperative voidings were markedly reduced in group C (219 and 218 ml, respectively) as compared with group A (383 and 453 ml) and with group B (319 and 414 ml, respectively). In group D, these mean volumes were significantly larger at 478 ml (p less than 0.01) and 417 ml (p less than 0.01) as compared with those of group C. The mean time to the first postoperative voiding was 582 min in group C, which was significantly longer than that in group A (339 min) or in group B (448 min). In the patients treated with phenoxybenzamine, the time to the first postoperative voiding was significantly less at 322 min (p less than 0.01). The need for bladder catheterization was also increased in group B compared with group A, while in group C this increase was marked compared with both groups A and B. It was significantly less frequent in those receiving phenoxybenzamine. Phenoxybenzamine is recommended in the prevention of postoperative urinary complications associated with epidural anaesthesia and epidural morphine analgesia.
对150例剖宫产术后患者进行了研究,以评估硬膜外吗啡镇痛及酚苄明对泌尿系统并发症的发生率和严重程度的影响。40例患者(A组)在全身麻醉下接受剖宫产手术,而110例患者接受硬膜外麻醉。在接受硬膜外麻醉的患者中,40例术后接受轻度镇痛药治疗(B组),另外40例术后接受硬膜外持续吗啡给药(C组)。30例接受术后硬膜外吗啡治疗的患者,在手术前24小时和1小时以及手术后8小时和16小时还口服了10毫克酚苄明(D组)。研究了术后首次排尿的尿量、首次排尿的时间延迟、排尿困难以及因尿潴留需要膀胱插管的情况。与A组(分别为383毫升和453毫升)和B组(分别为319毫升和414毫升)相比,C组术后首次排尿的平均尿量明显减少(分别为219毫升和218毫升)。在D组中,这些平均尿量与C组相比显著更大,分别为478毫升(p<0.01)和417毫升(p<0.01)。C组术后首次排尿的平均时间为582分钟,明显长于A组(339分钟)或B组(448分钟)。在接受酚苄明治疗的患者中,术后首次排尿时间明显缩短,为322分钟(p<0.01)。与A组相比,B组膀胱插管的需求也有所增加,而与A组和B组相比,C组的这种增加更为明显。在接受酚苄明治疗的患者中,这种情况明显较少见。推荐使用酚苄明预防与硬膜外麻醉和硬膜外吗啡镇痛相关的术后泌尿系统并发症。